55th Annual Meeting (October 28-November 2, 2008): Efficacy of Aripiprazole against Hostility in Adolescent Patients with Schizophrenia: Data from a Randomized, Placebo-Controlled Clinical Trial

Thursday, October 30, 2008: 11:30 AM

River Exhibition Hall (Sheraton Chicago Hotel & Towers)

Adelaide Robb, M.D., Children's National Medical Center, Washington, DC

William Carson, M.D., Otsuka Pharmaceutical Development and Commercialization, Inc., Princeton, NJ

Margaretta Nyilas, M.D., Otsuka Pharmaceutical Development and Commercialization, Inc., Princeton, NJ

Mirza Ali, Ph.D., Otsuka Pharmaceutical Development and Commercialization, Inc., Rockville

Robert D. McQuade, Ph.D.,

Robert A. Forbes, Ph.D., Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, NJ

Taro Iwamoto, Ph.D., Otsuka Pharmaceutical Development and Commercialization, Inc., Princeton, NJ

Sheila Assuncao-Talbott, M.D., Ph.D.,

Richard Whitehead, B.S., Medical Affairs, Otsuka America Pharmaceutical, Inc., Rockville, MD

Andrei Pikalov, M.D., Ph.D., Otsuka America Pharmaceutical, Inc., Rockville, MD

		56th Annual Meeting Tentative Program Schedule
		Please note that this schedule is subject to change. The Program Book distributed at the Annual Meeting will have final information on dates, times, and speakers for each presentation.

New Research Poster Presentation 3.7 Efficacy of Aripiprazole against Hostility in Adolescent Patients with Schizophrenia: Data from a Randomized, Placebo-Controlled Clinical Trial